Dear editor,
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- PRES and RCVS: two distinct entities or a spectrum of the same disease?.J Stroke Cerebrovasc Dis. 2022; 31106472https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2022.106472
- Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.Lancet Neurol. 2015; 14: 914-925https://doi.org/10.1016/S1474-4422(15)00111-8
- Reversible cerebral vasoconstriction syndrome.Lancet Neurol. 2012; 11: 906-917https://doi.org/10.1016/S1474-4422(12)70135-7
- Posterior Reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations.Front Neurol. 2020; 11: 34https://doi.org/10.3389/FNEUR.2020.00034/BIBTEX
- Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated spinal subdural hematoma: A case report.Medicine. 2020; 99: e21522https://doi.org/10.1097/MD.0000000000021522
- Endothelial cell infection and endotheliitis in COVID-19.Lancet. 2020; 395: 1417-1418
- COVID-19 and hypercoagulability: a review.Clin Appl Thromb. 2020; 26
- Multiple internal border zone infarcts in a patient with COVID-19 and CADASIL.J Neurol Sci. 2020; 416
- Ischemic stroke in a patient with stable CADASIL during COVID-19: A CASE Report.Brain Sci. 2021; 11https://doi.org/10.3390/BRAINSCI11121615
- Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.Nat Rev Immunol 2021 215. 2021; 21: 319-329https://doi.org/10.1038/s41577-021-00536-9
- The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.Stem Cell Reports. 2022; 17: 307-320https://doi.org/10.1016/J.STEMCR.2021.12.011
- Posterior reversible encephalopathy syndrome and brain haemorrhage as covid-19 complication: a review of the available literature.J Neurol. 2021; 268https://doi.org/10.1007/S00415-021-10709-0
- Brain MRI findings in COVID-19 patients with PRES: a systematic review.Clin Imaging. 2022; 81: 107-113https://doi.org/10.1016/J.CLINIMAG.2021.10.003
- COVID-19 associated reversible cerebral vasoconstriction syndrome successfully treated with nimodipine and aspirin.J Stroke Cerebrovasc Dis. 2021; 30105822https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.105822
- Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection.J Stroke Cerebrovasc Dis. 2020; 29https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2020.105011
- Fulminant reversible cerebral vasoconstriction syndrome in breakthrough covid 19 infection.J Stroke Cerebrovasc Dis. 2022; 31https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.106238
- Reversible cerebral vasoconstriction syndrome in patients with coronavirus disease: a multicenter case series.J Stroke Cerebrovasc Dis. 2021; 30https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.106118
Article info
Publication history
Published online: July 14, 2022
Accepted:
July 6,
2022
Received:
May 29,
2022
Publication stage
In Press Corrected ProofFootnotes
Search terms: PRES, RCVS, Endothelial dysfunction, COVID-19, SARS-CoV2
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106645
Copyright
© 2022 Elsevier Inc. All rights reserved.
